These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20678234)

  • 21. Puerarin Improves Vascular Insulin Resistance and Cardiovascular Remodeling in Salt-Sensitive Hypertension.
    Tan C; Wang A; Liu C; Li Y; Shi Y; Zhou MS
    Am J Chin Med; 2017; 45(6):1169-1184. PubMed ID: 28830209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline.
    Irwin N; Flatt PR; Patterson S; Green BD
    Eur J Pharmacol; 2010 Feb; 628(1-3):268-73. PubMed ID: 19917278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension.
    Tian N; Rose RA; Jordan S; Dwyer TM; Hughson MD; Manning RD
    J Hypertens; 2006 Nov; 24(11):2263-70. PubMed ID: 17053549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise training delays renal disorders with decreasing oxidative stress and increasing production of 20-hydroxyeicosatetraenoic acid in Dahl salt-sensitive rats.
    Ogawa Y; Takahashi J; Sakuyama A; Xu L; Miura T; Muroya Y; Ito D; Kohzuki M; Ito O
    J Hypertens; 2020 Jul; 38(7):1336-1346. PubMed ID: 32205560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes.
    Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
    Diabet Med; 2012 Dec; 29(12):1515-23. PubMed ID: 22540883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exenatide improves hypertension in a rat model of the metabolic syndrome.
    Laugero KD; Stonehouse AH; Guss S; Landry J; Vu C; Parkes DG
    Metab Syndr Relat Disord; 2009 Aug; 7(4):327-34. PubMed ID: 19320558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F; Fehmann HC; Göke R; Göke B
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertension.
    Zhou MS; Schulman IH; Raij L
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H833-9. PubMed ID: 19151253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exenatide can reduce glucose independent of islet hormones or gastric emptying.
    Ionut V; Zheng D; Stefanovski D; Bergman RN
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E269-77. PubMed ID: 18492781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Antihypertensive Effects of Esaxerenone with the Internal Sodium Balance in Dahl Salt-Sensitive Hypertensive Rats.
    Hattori M; Rahman A; Kidoguchi S; Jahan N; Fujisawa Y; Morisawa N; Ohsaki H; Kobara H; Masaki T; Hossain A; Steeve A; Nishiyama A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infusion of Valproic Acid Into the Renal Medulla Activates Stem Cell Population and Attenuates Salt-Sensitive Hypertension in Dahl S Rats.
    Wang Z; Zhu Q; Wang W; Yi F; Li PL; Boini KM; Li N
    Cell Physiol Biochem; 2017; 42(3):1264-1273. PubMed ID: 28693025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High salt-induced weakness of anti-oxidative function of natriuretic peptide receptor-C and podocyte damage in the kidneys of Dahl rats.
    Zhu XL; Zhang T; Xu ZQ; Ma XC; Wang ZJ; Zou CW; Li JX; Jing HY
    Chin Med J (Engl); 2020 May; 133(10):1182-1191. PubMed ID: 32433050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early treatment with GLP-1 after severe trauma preserves renal function in obese Zucker rats.
    Xiang L; Thompson MS; Clemmer JS; Mittwede PN; Khan T; Hester RL
    Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R621-R627. PubMed ID: 30811247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood pressure reduction by Japanese traditional Miso is associated with increased diuresis and natriuresis through dopamine system in Dahl salt-sensitive rats.
    Du DD; Yoshinaga M; Sonoda M; Kawakubo K; Uehara Y
    Clin Exp Hypertens; 2014; 36(5):359-66. PubMed ID: 24047246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GLP-1 receptor agonists have a sustained stimulatory effect on corticosterone release after chronic treatment.
    Krass M; Volke A; Rünkorg K; Wegener G; Lund S; Abildgaard A; Vasar E; Volke V
    Acta Neuropsychiatr; 2015 Feb; 27(1):25-32. PubMed ID: 25469828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P; Kramer HJ; Bäcker A; Malý J; Kopkan L; Vanecková I; Vernerová Z; Opocenský M; Tesar V; Bader M; Ganten D; Janda J; Cervenka L
    Kidney Blood Press Res; 2004; 27(4):248-58. PubMed ID: 15286437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel mechanism contributing to development of Dahl salt-sensitive hypertension: role of the transient receptor potential vanilloid type 1.
    Wang Y; Wang DH
    Hypertension; 2006 Mar; 47(3):609-14. PubMed ID: 16365187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
    Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA
    Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.